BerandaALTME • EPA
add
TME Pharma NV
Tutup sebelumnya
€0,067
Rentang hari
€0,070 - €0,077
Rentang tahun
€0,060 - €0,26
Kapitalisasi pasar
7,18Â jt EUR
Volume Rata-Rata
206,28Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
EPA
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (EUR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 9,50Â rb | 11,76% |
Biaya operasional | 1,27Â jt | -12,11% |
Laba bersih | -1,24Â jt | 19,60% |
Margin laba bersih | -13,02Â rb | 28,06% |
Penghasilan per saham | — | — |
EBITDA | -1,26Â jt | 12,07% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,24Â jt | 44,54% |
Total aset | 3,41Â jt | 36,73% |
Total liabilitas | 1,79Â jt | -35,66% |
Total ekuitas | 1,61 jt | — |
Saham yang beredar | 94,11 jt | — |
Harga terhadap nilai buku | 3,33 | — |
Tingkat pengembalian aset | -92,52% | — |
Tingkat pengembalian modal | -195,24% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -1,24Â jt | 19,60% |
Kas dari operasi | -949,50Â rb | 15,26% |
Kas dari investasi | -6,50 rb | — |
Kas dari pembiayaan | 1,23Â jt | 66,53% |
Perubahan kas bersih | 268,50Â rb | 170,38% |
Arus kas bebas | -738,62Â rb | 3,49% |
Tentang
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Didirikan
1997
Situs
Karyawan
12
